| 1. |
Vertes RP. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006;142:1-20.
|
| 2. |
Heidbreder CA, Groenewegen HJ. The medial prefrontal cortex in the rat: Evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neuro Sci Bio Behav Rev 2003;27:555-79.
|
| 3. |
Taber MT, Fibiger HC. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: Modulation by metabotropic glutamate receptors. J Neurosci 1995;15:3896-904.
|
| 4. |
Tzschentke TM. The medial prefrontal cortex as a part of the brain reward system. Amino Acids 2000;19:211-9.
|
| 5. |
Hao Y, Yang JY, Guo M, Wu CF, Wu MF. Morphine decreases extracellular levels of glutamate in the anterior cingulated cortex: An in vivo microdialysis study in freely moving rats. Brain Res 2005;1040:191-6.
|
| 6. |
Liang J, Ping XJ, Li YJ, Ma YY, Wu LZ, Han JS, et al. Morphine-induced conditioned place preference in rats is inhibited by electro acupuncture at 2 Hz: Role of encephalin in the nucleus accumbens. Neuropharmacology 2010;58:233-40.
|
| 7. |
Tzschentke TM, Schmidt WJ. Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit Rev Neurobiol 2000;14:131-42.
|
| 8. |
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 2002.
|
| 9. |
Juckel G, Mendlin A, Jacobs BL. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: Implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 1999;21:391-8.
|
| 10. |
Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2009;35:217-38.
|
| 11. |
Koob GF. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992;13:177-84.
|
| 12. |
Tzschentke TM. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 2001;63:241-320.
|
| 13. |
Hao Y, Yang J, Sun J, Qi J, Dong Y, Wu CF. Lesions of the medial prefrontal cortex prevent the acquisition but not reinstatement of morphine-induced conditioned place preference in mice. Neurosci Lett 2008;433:48-53.
|
| 14. |
You ZB, Tzschentke TM, Brodin E, Wise RA. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: An in vivo micro dialysis study in freely moving rats. J Neurosci 1998;18:6492-500.
|
| 15. |
Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. Opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U SA 2006;103:2938-42.
|
| 16. |
Kalivas PW, LaLumiere RT, Knackstedt L, Shen H. Glutamate transmission in addiction. Neuropharmacology 2009;56:169-73.
|
| 17. |
Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998;21:467-76.
|
| 18. |
Rajaei Z, Alaei H, Nasimi A, Amini H, Ahmadiani A. Ascorbate reduces morphine-induced extracellular DOPAC level in the nucleus accumbens: A micro dialysis study in rats. Brain Res 2005;1053:62-6.
|
| 19. |
Tzschentke TM, Schmidt WJ. Glutamatergic mechanisms in addiction. Molecular Psychiatry 2003;8:373-82.
|
| 20. |
Cowan A, Lewis JW, Macfarlane IR. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 1977;60:537-45.  [ PUBMED]
|
| 21. |
Gros C, Giros B, Schwartz JC. Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes. Biochemistry 1985;24:2179-85.  [ PUBMED]
|